Dentons ventureBeyond

SXSW VC Brunch with Capital Factory
2025-03-08 | SXSW
Dentons Global Venture Technology Group sponsored Capital Factory’s 6th annual VC Brunch, alongside Alpha Partners, Type One Ventures, National Venture Capital Association and Venture Atlanta Conference.
This invite-only brunch is held exclusively for VCs to connect with their peers and this year’s event welcomed 200+ VCs.

Sunset Sips: Investor & Founder Mixer at eMerge
2025-03-27 17:30 - 20:30 (America/New_York) | Miami Beach, Florida
Join us during eMerge Americas for a happy hour mixer! Unwind after a busy day, mingle with fellow innovators, entrepreneur and investors to enjoy delicious cocktails and great conversation in a cool venue.

Webinar: The Rise of the Secondary Market
2025-05-13 13:00 - 14:00
Victor H. Boyajian, Global Chair of Dentons’ Venture Technology and Emerging Growth Companies group, sat down with Christina Fa, Principal at NewView Capital; Chris Bull, Managing Director at Kline Hill Partners; and Matt Krna, Founder and Managing Partner at Two Meter Capital, for a candid discussion on the evolving secondary market. They dove into what’s driving the surge in activity, the distinct dynamics between venture and private equity secondaries, and how investors, founders, and fund managers are approaching liquidity — including deal structuring, market pricing and emerging strategies.
The recording can be found below:
Dentons – The Rise of the Secondary Market

Spring into Summer: A Rooftop Gathering with GV & Dentons
2025-05-20 17:00 - 19:00 | New York, NY
Join GV and Dentons as we Spring into Summer, bringing together NYC’s brightest founders, investors and innovators for a relaxed gathering to kick off the season.
​Rooftop views and conversations that spark what’s ahead!

Brexfast Club w/ FirstGen Founders, Operators and Investors
2025-06-03 09:00 - 10:30 | New York, NY
Join us for Brexfast Club co-hosted with ​FirstGen and One Way Ventures and connect with immigrant and first-gen Founders, Operators & VCs during #NYTechWeek.

Taco Tuesday: NYC Founders & Investors
2025-06-03 18:00 - 21:00 | New York, NY
Join us during #NYTechWeek for a cocktail mixer and small bites for the chance to meet New York City’s earliest founders and investors, including Bling Capital, Correlation Ventures, Max Ventures, Daybreak, Field Ventures and BBG Ventures.

NY Tech Week Investor & Founder Mixer with Rayo Capital, W3F, Stand with Crypto and Draper University Ventures
2025-06-04 18:00 - 21:00 | New York, NY
​​Join Rayo, W3F, Stand with Crypto and Draper University Ventures for an evening of connection, collaboration, and community! We welcome everyone in town for NYC Tech Week to join our community of founders, developers and builders to join us over light refreshments.

GCV London Symposium Sector Spotlight Panel: National Security & Defense Technology
2025-06-18 10:55 - 11:25 | London
From AI-driven threat detection to quantum-resistant encryption, the next wave of defense technology is being shaped by innovative startups and strategic investors. Moderated by Dentons Global Venture Technology Chair Victor Boyajian, this panel will uncover how venture capital, government partnerships and breakthrough technologies are converging to address national security challenges.

Q2 2025 PitchBook-NVCA Venture Monitor Webinar
2025-07-31 13:00 - 14:00
Halfway through 2025, the venture market remains defined by liquidity concerns and surging interest in AI. Investment power has concentrated among firms with ample dry powder and established track records. Meanwhile, tariffs and geopolitical uncertainty continue to dampen IPO prospects despite a recent surge in new public listings, while a handful of billion-dollar M&A deals closed in Q2, driven in large part by highly capitalized, VC-backed companies.
In this webinar, created in partnership with the National Venture Capital Association (NVCA), our panel of experts examine current US VC trends, analyze their impact on the market moving forward, and offer their perspectives on the rest of the year’s outlook.
Key topics

Down round IPOs are the new normal
Secondaries have provided some limited liquidity relief
Dealmaking continues its focus on AI
Fundraising is waiting on a return of large exits

Investing at the Frontier: AI, Sustainability and Resilience in 2025 with GV, IQT and Drive Capital
2025-09-30 13:00 - 14:00
The venture landscape is evolving rapidly, with institutional capital flowing into areas that are shaping both markets and society. From the infrastructure enabling AI to dual-use technologies bridging commercial and national security needs, investors are seeking opportunities that combine innovation with resilience.
Join leaders from GV, IQT and Dentons for a virtual conversation that explores how global forces, technological breakthroughs and shifting capital dynamics are defining the next wave of early- and growth-stage investing.
Discussion highlights:

AI today and tomorrow: Applied AI vs. infrastructure and where long-term value lies.
Dual-use innovation: Robotics, space, cybersecurity, biotech and advanced manufacturing.
Energy and sustainability: Tackling datacenter and EV-driven energy demand.
Resilience in uncertain times: Conflict, supply chains and global volatility.
What founders must demonstrate: Traction and focus in today’s tighter fundraising market.

Capital at the Crossroads: Navigating Today’s Life Sciences Market Realities with ThinkEquity and Nasdaq
2025-10-08 13:00 - 14:00
Dentons is launching a new roundtable series for biotech, pharma and med device leaders—bringing market experts and investors together to share clear perspectives on today’s capital markets, from current challenges to emerging opportunities.
Episode 1: State of the Markets
Our first session will spotlight the realities of today’s financing and deal-making climate. Hear directly from Tara Sharif, PhD, MBA, Managing Director at ThinkEquity and Andy Hall, Senior Managing Director at Nasdaq as they share perspectives on where the markets stand, what’s moving the needle and what companies should be preparing for in the year ahead.
Guiding the conversation will be Dentons’ own Ira Kotel and Rob Condon, who bring decades of experience at the intersection of life sciences and capital markets. Together, they’ll frame the discussion around practical insights for companies considering fundraising, public listings or strategic transactions.
Key topics include:

Current fundraising conditions and how they are reshaping biotech, pharma and med device strategies.
IPO and follow-on market activity—what it takes to go public in today’s climate.
M&A and partnership trends, including what acquirers and investors are looking for.
